A concentrated audience of pharma R&D leaders, biotech founders, and investors — across a flagship platform, two newsletters, and a 50,000-strong LinkedIn presence.
Our channels differ in nature and reach very different readers — so each is profiled on its own. Figures are sample placeholders; our analyst replaces the numbers (update the % and its bar width) and drops a real analytics screenshot into each slot.
Permanent, definitive analysis of AI in drug discovery and pharma R&D — the SEO/GEO anchor and a broad global readership arriving via search.
Weekly deep dives into AI drug discovery, computational biology, and pharma R&D — a technical, highly engaged subscriber base.
Curated weekly intelligence on AI in drug discovery and competitive dynamics — skews senior, decision-maker heavy.
High-velocity analysis and industry takes across three channels — the broadest, most varied slice of the audience.
Dedicated placements in Where Tech Meets Bio and The Biotech Edge, in front of an engaged subscriber base.
Sponsored takes and placements across a 50,000-follower community of industry decision-makers.
Co-hosted webinars pairing your platform with our editorial credibility and audience reach.
Flagship analytical reports produced with our editorial team and distributed across the brand.
Sponsored landscape maps tied to hot topics, positioning your category and your platform within it.
Editorially-framed, verified profiles that sit under the trusted brand — not a dry directory listing.
Our readers are the people who decide: venture investors sourcing deal flow, pharma R&D and BD teams scouting technology, biotech founders and operators, and the platform companies building the tools. Concentrated, senior, and hard to reach through generic channels.
Full demographics, reach by channel, formats, and rates.